Research programme: GIPR/GLP-1R agonists - MedImmune

Drug Profile

Research programme: GIPR/GLP-1R agonists - MedImmune

Alternative Names: GIP/GLP1; GIP/GLP1 agonists; Gipg013; GIPR/GLP-1R

Latest Information Update: 27 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator MedImmune
  • Class
  • Mechanism of Action Gastric inhibitory polypeptide receptor agonists; Glucagon like peptide 1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Diabetes mellitus

Most Recent Events

  • 27 Sep 2016 Preclinical trials in Diabetes mellitus in USA (SC)
  • 12 Sep 2016 Pharmacodynamics data from a preclinical trial presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes (EASD-2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top